- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroectodermal Tumors, Primitive, Peripheral in New Zealand
Total 1569 results
-
Novartis PharmaceuticalsCompleted
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorUnited States
-
Nina BhardwajCancer Research Institute, New York City; Ludwig Institute for Cancer Research and other collaboratorsCompleted
-
The New York Eye Cancer CenterGenentech, Inc.CompletedRadiation Retinopathy | Choroidal MelanomaUnited States
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
ActelionCompleted
-
Bristol-Myers SquibbMedarexCompleted
-
Yale UniversityCompletedMelanoma | Lung CancerUnited States
-
Idera Pharmaceuticals, Inc.CompletedMelanoma | Refractory Solid TumorsUnited States, Israel
-
Gulam ManjiDaiichi SankyoActive, not recruitingSarcoma | Malignant Peripheral Nerve Sheath TumorsUnited States
-
Melanoma Institute AustraliaActive, not recruiting
-
Callisto PharmaceuticalsCompletedNeuroendocrine CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Northwell HealthRecruitingCancer | Glioblastoma | Brain Cancer | Brain Tumor | Brain Tumor, Primary | Brain Tumor Adult | Glioma of Brain | Glioblastoma, Adult | Glioblastoma Multiforme (GBM)United States
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroendocrine Carcinoma | Carcinoma of Unknown Primary | Neuroendocrine Carcinoma of the SkinUnited States
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Rockefeller UniversityCompletedMelanoma | Neoplasm MetastasisUnited States
-
IncuronCompletedGlioblastoma | Solid TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
NYU Langone HealthCompletedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)WithdrawnStage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
IpsenTerminatedNeuroendocrine Tumors in LungCanada, United States, Germany, France, United Kingdom, Netherlands, Spain, Denmark, Italy, Austria, Poland
-
Trans Tasman Radiation Oncology GroupCompleted
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Genta IncorporatedCompletedDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaMelanoma (Skin)United States
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Molecular Insight Pharmaceuticals, Inc.UnknownPheochromocytoma | ParagangliomaUnited States
-
Genentech, Inc.Terminated
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
GlaxoSmithKlineUnknownMelanoma (Skin)United States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Matthew InghamTakeda; Karyopharm Therapeutics IncWithdrawnSarcoma | Ewing Sarcoma | Liposarcoma | Alveolar Soft Part Sarcoma | Malignant Peripheral Nerve Sheath TumorsUnited States
-
Helsinn Healthcare SALabcorp Drug Development IncWithdrawnAdvanced Solid Tumor | CNS Tumor | Recurrent WHO Grade II GliomaUnited States, Canada, Germany
-
Provectus PharmaceuticalsCompleted
-
Ruhr University of BochumCompleted